These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1083 related articles for article (PubMed ID: 9618421)
1. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat. Hammond DL; Wang H; Nakashima N; Basbaum AI J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201 [TBL] [Abstract][Full Text] [Related]
3. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831 [TBL] [Abstract][Full Text] [Related]
4. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. Stewart PE; Hammond DL J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918 [TBL] [Abstract][Full Text] [Related]
5. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord. Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269 [TBL] [Abstract][Full Text] [Related]
6. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype. Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156 [TBL] [Abstract][Full Text] [Related]
8. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice. Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282 [TBL] [Abstract][Full Text] [Related]
9. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat. Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450 [TBL] [Abstract][Full Text] [Related]
10. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay. Sterious SN; Walker EA J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605 [TBL] [Abstract][Full Text] [Related]
11. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. Rady JJ; Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196 [TBL] [Abstract][Full Text] [Related]
12. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214 [TBL] [Abstract][Full Text] [Related]
13. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone. Hammond DL; Stewart PE; Littell L J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504 [TBL] [Abstract][Full Text] [Related]
14. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site. Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752 [TBL] [Abstract][Full Text] [Related]
15. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes. Mattia A; Vanderah T; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835 [TBL] [Abstract][Full Text] [Related]
16. Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors. Riba P; Ben Y; Smith AP; Furst S; Lee NM J Pharmacol Exp Ther; 2002 Jan; 300(1):265-72. PubMed ID: 11752125 [TBL] [Abstract][Full Text] [Related]
17. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides. Kiritsy-Roy JA; Marson L; Van Loon GR J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411 [TBL] [Abstract][Full Text] [Related]
18. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes. Cahill CM; White TD; Sawynok J J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600 [TBL] [Abstract][Full Text] [Related]
19. N-acetyl beta-endorphin-(1-31) and substance P regulate the supraspinal antinociception mediated by mu opioid and alpha-2 adrenoceptors but not by delta opioid receptors in the mouse. Sánchez-Blázquez P; Garzón J J Pharmacol Exp Ther; 1993 May; 265(2):835-43. PubMed ID: 7684446 [TBL] [Abstract][Full Text] [Related]
20. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum. Mitrovic I; Napier TC J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]